SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-083595
Filing Date
2024-04-01
Accepted
2024-04-01 17:15:32
Documents
13
Period of Report
2024-03-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d809386d8k.htm   iXBRL 8-K 21829
  Complete submission text file 0001193125-24-083595.txt   140450

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA itci-20240327.xsd EX-101.SCH 2894
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20240327_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20240327_pre.xml EX-101.PRE 10841
16 EXTRACTED XBRL INSTANCE DOCUMENT d809386d8k_htm.xml XML 3481
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 24810902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)